Laboratorios Farmaceuticos Rovi, S.A.

BME-ROVI
Madrid Stock Exchange
Healthcare Drug Manufacturers - Specialty & Generic
Global Rank
#4537
Country Rank
#38
Market Cap
3.42 B
Price
67.21
Change (%)
0.52%
Volume
51,936

BME-ROVI's Next Dividend

Next Estimated Amount
€0.642
Next Estimated Pay Date
07/22/2026
Last Amount
€0.757
Last Pay Date
07/16/2025
Dividend Shot Clock Ex-Date: 07/14/2025
0
Days
0
Hours
0
Minutes
0
Seconds
Ex-dividend date passed

Laboratorios Farmaceuticos Rovi, S.A. Dividend Chart

*Amounts are shown in the stock exchange currency (EUR) for convenience

Laboratorios Farmaceuticos Rovi, S.A.(BME-ROVI) Dividend History

Laboratorios Farmaceuticos Rovi, S.A. (BME-ROVI) currently pays an annual dividend of $0.76 per share, offering a dividend yield of 1.66%. The next dividend payout date has not been announced.
Ex-Dividend Date Amount Adj. Amount Dividend Yield Pay Date Change (%)
2025 €0.757 €0.757 -15%
07/14/2025 €0.757 €0.757 n/a 07/16/2025 -15%
2024 €0.894 €0.894 -15%
07/08/2024 €0.894 €0.894 n/a 07/10/2024 -15%
2023 €1.05 €1.05 35%
07/03/2023 €1.05 €1.05 n/a 07/05/2023 35%
2022 €0.774 €0.774 151%
07/05/2022 €0.774 €0.774 n/a 07/07/2022 151%
2021 €0.309 €0.309 118%
07/05/2021 €0.309 €0.309 n/a 07/07/2021 118%
2020 €0.142 €0.142
11/17/2020 €0.142 €0.142 n/a 11/19/2020
*Amounts are shown in the stock exchange currency (EUR) for convenience
*Historical information is adjusted for stock splits

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.